• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国绝经后女性的骨折风险:体重指数、年龄和骨密度的影响。

Fracture risk in Korean postmenopausal women: The influence of BMI, age, and bone density.

作者信息

Shin Junghwa, Kim Kwang Yoon, Park Joo-Hyun, Lee Sangmi, Noh O Kyu, Choi Yong Jun, Chung Yoon-Sok, Kim Bom-Taeck

机构信息

Department of Family Medicine, Korea University College of Medicine, Ansan, South Korea.

Department of Family Practice and Community Health, Ajou University School of Medicine, Suwon, South Korea.

出版信息

Osteoporos Sarcopenia. 2025 Jun;11(2):65-68. doi: 10.1016/j.afos.2025.03.001. Epub 2025 Apr 8.

DOI:10.1016/j.afos.2025.03.001
PMID:40677783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12266163/
Abstract

OBJECTIVES

Fracture risk in postmenopausal women is influenced by bone mineral density (BMD), age, and body mass index (BMI). However, fracture prevention strategies primarily focus on low BMD, often overlooking other key factors.

METHODS

This retrospective cohort study analyzed 18,151 Korean postmenopausal women aged 50 or older who underwent dual-energy X-ray absorptiometry (DXA) at Ajou University Hospital from years of 2006-2014. Fracture risk was assessed using multivariable Cox proportional hazard models, adjusted for BMI, BMD, and age.

RESULTS

The median age of the cohort was 59.1 years, and the overall fracture incidence was 2.3 per 1,000 person-years. Fracture risk significantly increased with age, with hazard ratios (HRs) of 1.36 (95% CI: 1.08-1.70) for women aged 60-69 and 2.10% (95% CI: 1.62-2.73) for those aged 70 or older, compared to the reference group (50-59 years). Underweight women exhibited the highest fracture cumulative incidence (3.3%), though their risk increase was not statistically significant. Overweight and obese women demonstrated higher BMD but did not show significant fracture risk reductions.

CONCLUSIONS

These findings highlight age as a dominant predictor of fracture risk, while BMI plays a complex, less pronounced role. The discrepancy between osteoporosis prevalence and actual fracture risk, particularly in obese elderly women, suggests limitations in BMD-focused assessments. Simple, measurable parameters like age and BMI should complement BMD in fracture risk evaluation to better target high-risk populations and enhance preventive strategies in clinical practice.

摘要

目的

绝经后女性的骨折风险受骨密度(BMD)、年龄和体重指数(BMI)影响。然而,骨折预防策略主要侧重于低骨密度,常常忽视其他关键因素。

方法

这项回顾性队列研究分析了2006年至2014年在阿朱大学医院接受双能X线吸收法(DXA)检查的18151名年龄在50岁及以上的韩国绝经后女性。使用多变量Cox比例风险模型评估骨折风险,并对BMI、BMD和年龄进行了调整。

结果

该队列的中位年龄为59.1岁,总体骨折发生率为每1000人年2.3例。骨折风险随年龄显著增加,与参考组(50 - 59岁)相比,60 - 69岁女性的风险比(HR)为1.36(95%CI:1.08 - 1.70),70岁及以上女性为2.10(95%CI:1.62 - 2.73)。体重过轻的女性骨折累积发生率最高(3.3%),尽管其风险增加无统计学意义。超重和肥胖女性骨密度较高,但骨折风险并未显著降低。

结论

这些发现突出了年龄是骨折风险的主要预测因素,而BMI的作用复杂且不那么明显。骨质疏松症患病率与实际骨折风险之间的差异,尤其是在肥胖老年女性中,表明以骨密度为重点的评估存在局限性。年龄和BMI等简单可测量参数应在骨折风险评估中补充骨密度,以便更好地针对高危人群并加强临床实践中的预防策略。

相似文献

1
Fracture risk in Korean postmenopausal women: The influence of BMI, age, and bone density.韩国绝经后女性的骨折风险:体重指数、年龄和骨密度的影响。
Osteoporos Sarcopenia. 2025 Jun;11(2):65-68. doi: 10.1016/j.afos.2025.03.001. Epub 2025 Apr 8.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
4
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.阿仑膦酸盐、依替膦酸盐、利塞膦酸盐、雷洛昔芬和特立帕肽用于预防和治疗绝经后骨质疏松症的系统评价与经济学评估
Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220.
5
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
6
Hormone therapy and increased risk of psoriasis in reproductive-age and postmenopausal women: a nationwide cohort study and target trial emulation.激素疗法与育龄期及绝经后女性患银屑病风险增加:一项全国性队列研究及目标试验模拟
Br J Dermatol. 2025 Jul 17;193(2):259-266. doi: 10.1093/bjd/ljaf179.
7
Visceral Adipose Tissue, Aortic Distensibility and Atherosclerotic Cardiovascular Risk Across Body Mass Index Categories.不同体重指数类别下的内脏脂肪组织、主动脉可扩张性与动脉粥样硬化性心血管风险
Eur J Prev Cardiol. 2025 Jul 18. doi: 10.1093/eurjpc/zwaf447.
8
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.雷奈酸锶预防绝经后妇女骨质疏松性脆性骨折的临床有效性和成本效益。
Health Technol Assess. 2007 Feb;11(4):1-134. doi: 10.3310/hta11040.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Strontium ranelate for preventing and treating postmenopausal osteoporosis.雷奈酸锶用于预防和治疗绝经后骨质疏松症。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD005326. doi: 10.1002/14651858.CD005326.pub2.

本文引用的文献

1
Osteopenia: a key target for fracture prevention.骨质疏松症:骨折预防的关键目标。
Lancet Diabetes Endocrinol. 2024 Nov;12(11):856-864. doi: 10.1016/S2213-8587(24)00225-0. Epub 2024 Sep 23.
2
Update on fracture risk assessment in osteoporosis.骨质疏松症骨折风险评估的最新进展。
Curr Opin Endocrinol Diabetes Obes. 2024 Aug 1;31(4):141-148. doi: 10.1097/MED.0000000000000871. Epub 2024 May 29.
3
Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project.治疗前骨密度与药物治疗对骨折风险和 BMD 变化的获益:FNIH-ASBMR SABRE 项目分析。
J Bone Miner Res. 2024 Aug 5;39(7):867-876. doi: 10.1093/jbmr/zjae068.
4
Risk of fracture according to temporal changes of low body weight changes in adults over 40 years: a nationwide population-based cohort study.40 岁以上成年人低体重变化的时间变化与骨折风险:一项全国基于人群的队列研究。
BMC Public Health. 2023 May 25;23(1):948. doi: 10.1186/s12889-023-15940-0.
5
Effect of body mass index on vertebral and hip fractures in older people and differences according to sex: a retrospective Japanese cohort study.体重指数对老年人椎体和髋部骨折的影响及性别差异:一项回顾性日本队列研究。
BMJ Open. 2021 Nov 9;11(11):e049157. doi: 10.1136/bmjopen-2021-049157.
6
Change in BMI affects the risk of falling in postmenopausal osteopenic and osteoporotic women.体重指数的变化会影响绝经后骨质减少和骨质疏松女性的跌倒风险。
J Frailty Sarcopenia Falls. 2021 Jun 1;6(2):86-91. doi: 10.22540/JFSF-06-086. eCollection 2021 Jun.
7
Osteoporosis Detection by Physical Function Tests in Resident Health Exams: A Japanese Cohort Survey Randomly Sampled from a Basic Resident Registry.居民健康检查中通过身体功能测试检测骨质疏松症:一项从基本居民登记册中随机抽样的日本队列研究
J Clin Med. 2021 Apr 27;10(9):1896. doi: 10.3390/jcm10091896.
8
Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.评估韩国50岁及以上女性抗骨质疏松药物国家健康保险报销政策修订的效果。
PLoS One. 2020 Dec 31;15(12):e0244759. doi: 10.1371/journal.pone.0244759. eCollection 2020.
9
The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.骨质疏松症治疗差距:欧洲初级保健中骨折风险患者的多国家横断面观察性研究。
Osteoporos Int. 2021 Feb;32(2):251-259. doi: 10.1007/s00198-020-05557-z. Epub 2020 Aug 23.
10
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE .美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(5):564-570. doi: 10.4158/GL-2020-0524.